Valeo Pharma Inc. (VPHIF)

OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Feb 11, 2026
-100.00%
Market Cap 99.00
Revenue (ttm) 38.64M
Net Income (ttm) -23.25M
Shares Out 98.68M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,000
Average Volume 457,599
Open 0.0000
Previous Close 0.0001
Day's Range 0.0000 - 0.0000
52-Week Range 0.0000 - 0.0003
Beta 0.84
RSI 36.87
Earnings Date n/a

About Valeo Pharma

Valeo Pharma Inc. operates as a pharmaceutical company focused on licensing, acquiring, and commercializing drugs. The company provides commercialized pharmaceutical products in Canada, with a focus on respiratory/allergy, ophthalmology, and specialty therapeutic areas. It licenses and acquires Canadian rights to commercial-stage and proprietary drugs, managing registration and commercialization through all stages. The company offers access to product specialists and medical information for healthcare professionals and patients. Valeo Pharma se... [Read more]

Sector Healthcare
Founded 2003
Employees 70
Stock Exchange OTCMKTS
Ticker Symbol VPHIF
Full Company Profile

Financial Performance

In fiscal year 2023, Valeo Pharma's revenue was 53.91 million, an increase of 94.31% compared to the previous year's 27.75 million. Losses were -27.81 million, 8.01% more than in 2022.

Financial numbers in CAD Financial Statements

News

There is no news available yet.